7:00 am – 3:00 pm
Registration Open
7:15 am – 8:30 am
Breakfast / Product Theater (Non-CE)
Case-based Learnings on a Treatment Approach for Certain Patients With High-Risk Non-muscle Invasive Bladder Cancer
Anne E. Calvaresi, NP
Sponsored by Merck
8:40 am – 9:40 am
General Session
Interstitial Cystitis: Understanding Bladder Pain Syndrome
Erika Poderis, DNP, FNP-BC
The purpose of this presentation is to provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS), including discussion of treatments that should and should not be offered in the office setting by the advanced practice nurse.
9:50 am – 10:50 am
General Session
Advanced Interpretation of Urodynamic Tests
Mikel Gray, RN, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN
This session will focus on advanced concepts related to interpretation of complex multichannel urodynamic testing, including pressure flow nomograms; calculation of bladder wall compliance; and assessment of urethral sphincter incompetence.
11:00 am – 12:00 pm
General Session
Transgender Health and Gender Affirming Surgery: Nursing Considerations
Laura Douglass, MD
We will review transgender health and how to provide gender affirming care. We also will discuss gender affirming surgery and nursing care and considerations.
12:10 pm – 1:10 pm
CE Lunch Symposium
Metastatic Hormone-Sensitive Prostate Cancer: New Treatment Options
Leanne Schimke, MSN, CRNP, CUNP, FNP-C
Sponsored by an unrestricted grant from Bayer HealthCare Pharmaceuticals Inc.
1:20 pm – 2:20 pm
General Session
Benign Urologic Conditions for the APP
Adele Caruso, DNP, CRNP, FAANP
There are many common but benign urologic conditions. Among them are hematuria, urinary tract infections (UTIs), kidney stones, and kidney cysts. This presentation will encompass a discussion relative to the recognition and management of these conditions and specifically address the role of the urology advanced practice provider (APP).
2:30 pm – 3:30 pm
General Session
Neurogenic Bladder & Bowel: An Overview in Etiology, Diagnosis, and Treatment from Gestation to Gerontology
Joy Kerr, DNP, CPNP-PC, CRNFA
Neurogenic bladder and neurogenic bowel occur in patients who have congenital anomalies, tumors/diseases of the central nervous system, spinal cord injuries, and stroke. We will review etiology, diagnosis, and treatments for both neurogenic bladder and bowel in these complex patients from gestation to gerontology.